Ubs Global Asset Management Americas »

Corcept Therapeutics Incorporated shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1M 125k 32.48
2023-09-30 $3.3M 121k 27.25
2023-06-30 $2.9M 133k 21.66
2023-03-31 $2.9M 133k 21.66
2022-12-31 $2.6M 130k 20.31
2022-09-30 $3.4M 133k 25.64
2022-06-30 $3.9M 164k 23.78
2022-03-31 $3.8M 168k 22.52
2021-12-31 $3.0M 150k 19.80
2021-09-30 $2.9M 148k 19.68
2021-06-30 $3.0M 138k 22.00
2021-03-31 $3.2M 133k 23.79
2020-12-31 $1.9M 109k 17.41
2020-09-30 $1.9M 109k 17.41
2020-06-30 $1.9M 110k 16.82
2020-03-31 $1.3M 106k 11.89
2019-12-31 $955k 79k 12.10
2019-09-30 $1.4M 98k 14.13
2019-06-30 $817k 73k 11.15
2019-03-31 $1.1M 91k 11.74
2018-12-31 $1.1M 80k 13.36
2018-09-30 $947k 68k 14.02
2018-06-30 $1.0M 65k 15.72
2018-03-31 $1.1M 64k 16.45
2017-12-31 $1.0M 57k 18.06
2017-09-30 $766k 40k 19.30
2017-06-30 $454k 39k 11.80
2017-03-31 $507k 46k 10.96
2016-12-31 $120k 17k 7.23
2016-09-30 $256k 39k 6.50
2016-06-30 $215k 39k 5.46
2016-03-31 $184k 39k 4.67
2015-12-31 $173k 35k 4.99
2015-09-30 $130k 35k 3.75
2015-06-30 $209k 35k 6.02
2013-09-30 $87k 55k 1.59
2013-06-30 $95k 55k 1.73